Search results (24)
« Back to PublicationsTumor-specific CD8 T cell characterization in HR+ breast cancer reveals an impaired antitumoral response in patients with lymph node metastasis.
Pinho MP. et al, (2025), Cell Rep Med, 6
Profiling of Tumor-Infiltrating Immune Cells and Their Impact on Survival in Glioblastoma Patients Undergoing Immunotherapy with Dendritic Cells.
Peres N. et al, (2024), Int J Mol Sci, 25
A robust deep learning workflow to predict CD8 + T-cell epitopes.
Lee CH. et al, (2023), Genome Med, 15
Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial.
Lepski G. et al, (2023), Cancers (Basel), 15
Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell-mediated toxicity against glioblastoma.
Ma R. et al, (2022), Neuro Oncol, 24, 2093 - 2106
HLA-dependent variation in SARS-CoV-2 CD8 + T cell cross-reactivity with human coronaviruses.
Buckley PR. et al, (2022), Immunology, 166, 78 - 103
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk . and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium ., (2022), Cell, 185, 916 - 938.e58
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium . et al, (2021)
Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.
Lee CH. et al, (2020), Front Immunol, 11
Frequency determination of breast tumor-reactive CD4 and CD8 T cells in humans: unveiling the antitumor immune response.
Pinho MP. et al, (2019), Oncoimmunology, 8